|
Scientist
>
Prof. Gert Fricker
Prof. Gert Fricker
studied chemistry and medicine at the University of Freiburg. After obtaining his doctorate in biochemistry in 1986, he completed his habilitation in experimental medicine in 1993. Following a postdoc position at UniversityHospital Zurich, he then joined the Drug Delivery System department at Sandoz AG in Basel in 1988. In 1995, he accepted a position at the Institute for Pharmaceutical Technology and Biopharmacy at the University of Heidelberg. Appointed Director of the new Institute of Pharmacy and Molecular Biotechnology in 2002, he is also managing director of the Heidelberg-based Steinbeis Technology Transfer Centre Biopharmacy and Analytics. His research interests include membrane transport processes, innovative dosage forms and API transport through the blood-brain barrier. Contact: laborundmore@succidia.deComplex API deliveryCellular transport proteins and API transport - von Prof. Gert Fricker, Dr. Anne Mahringer
A medicine's potency often depends on the concentration of its active ingredient (API) at the target site. Medicines are usually delivered remotely to this target site, however. The API must first dissolve and traverse local barriers such as the intestinal wall before it can enter the bloodstream and then reach its target site. For a long time, work in this area was guided by the dogma that API diffusion was the force driving absorption by the body...
 |
|
Search:
